Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
出版年份 2023 全文链接
标题
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
作者
关键词
-
出版物
MOLECULAR ASPECTS OF MEDICINE
Volume 93, Issue -, Pages 101205
出版商
Elsevier BV
发表日期
2023-07-27
DOI
10.1016/j.mam.2023.101205
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways
- (2023) Claudia Tito et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells
- (2022) Rachel E. Nicoletto et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The effects of doxorubicin on cardiac calcium homeostasis and contractile function
- (2022) Krekwit Shinlapawittayatorn et al. Journal of Cardiology
- Salidroside Promotes Sensitization to Doxorubicin in Human Cancer Cells by Affecting the PI3K/Akt/HIF Signal Pathway and Inhibiting the Expression of Tumor-Resistance-Related Proteins
- (2022) Qi Zeng et al. JOURNAL OF NATURAL PRODUCTS
- Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review
- (2022) Mihad Ibrahim et al. Pharmaceutics
- Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells
- (2022) Natalia I. Moiseeva et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Oxidative stress‐mediated up‐regulation of ABC transporters in lung cancer cells
- (2022) Tongkuo Yuan et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
- (2022) Mahshid Deldar Abad Paskeh et al. LIFE SCIENCES
- Potential of Ferritin-Based Platforms for Tumor Immunotherapy
- (2022) Xiaoling Xu et al. MOLECULES
- Iron Promotes Cardiac Doxorubicin Retention and Toxicity Through Downregulation of the Mitochondrial Exporter ABCB8
- (2022) Archita Venugopal Menon et al. Frontiers in Pharmacology
- The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review
- (2022) Zihan Si et al. Frontiers in Oncology
- Doxorubicin-Based Hybrid Compounds as Potential Anticancer Agents: A Review
- (2022) Sijongesonke Peter et al. MOLECULES
- PX478-loaded silk fibroin nanoparticles reverse multidrug resistance by inhibiting the hypoxia-inducible factor
- (2022) Zheng Li et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α
- (2022) Jiali Zhao et al. Drug Design Development and Therapy
- Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin
- (2022) Wang Yin et al. Biomolecules
- A Comprehensive Review on Alginate-based Delivery Systems for the Delivery of Chemotherapeutic Agent: Doxorubicin
- (2021) Jaya R. Lakkakula et al. CARBOHYDRATE POLYMERS
- Targeting OCT3 attenuates doxorubicin-induced cardiac injury
- (2021) Kevin M. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway
- (2021) Xianglan Yi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells
- (2021) Amir Sadra Zangouei et al. Cancer Cell International
- Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance
- (2021) Guo-Hua Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Regulated cell death pathways in doxorubicin-induced cardiotoxicity
- (2021) Effimia Christidi et al. Cell Death & Disease
- Overcoming Chemoresistance via Extracellular Vesicle Inhibition
- (2021) Raeesah Hayatudin et al. Frontiers in Molecular Biosciences
- The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update
- (2021) Zahra Torki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Long non-coding RNAs in the doxorubicin resistance of cancer cells
- (2021) Saeed Ashrafizaveh et al. CANCER LETTERS
- Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
- (2021) Lingyue Gao et al. DRUG RESISTANCE UPDATES
- Structural Basis of Drug Recognition by the Multidrug Transporter ABCG2
- (2021) Julia Kowal et al. JOURNAL OF MOLECULAR BIOLOGY
- Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
- (2021) Navneet Joshi et al. LIFE SCIENCES
- Calcium channel blockers lercanidipine and amlodipine inhibit YY1/ERK/TGF-β mediated transcription and sensitize the gastric cancer cells to doxorubicin
- (2021) Ponmathi Panneerpandian et al. TOXICOLOGY IN VITRO
- MiR-194-5p enhances the sensitivity of nonsmall-cell lung cancer to doxorubicin through targeted inhibition of hypoxia-inducible factor-1
- (2021) Mengning Xia et al. World Journal of Surgical Oncology
- CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1
- (2021) Hong Luo et al. Cell Death & Disease
- Inhibition of Exosome Release Sensitizes U937 Cells to PEGylated Liposomal Doxorubicin
- (2021) Shirin Hekmatirad et al. Frontiers in Immunology
- CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway
- (2021) Usama Khamis Hussein et al. Cells
- Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
- (2021) Sepideh Mirzaei et al. DRUG DISCOVERY TODAY
- The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets
- (2021) Sepideh Mirzaei et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Expression and Functional Contribution of Different Organic Cation Transporters to the Cellular Uptake of Doxorubicin into Human Breast Cancer and Cardiac Tissue
- (2021) Marcus Otter et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years
- (2021) Natália A. D'Angelo et al. Materials Science & Engineering C-Materials for Biological Applications
- Anthracyclines: biosynthesis, engineering and clinical applications
- (2021) Mandy B. Hulst et al. NATURAL PRODUCT REPORTS
- Protein-Based Nanoparticles for the Imaging and Treatment of Solid Tumors: The Case of Ferritin Nanocages, a Narrative Review
- (2021) Francesco Mainini et al. Pharmaceutics
- SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway
- (2020) Shan Tian et al. Aging-US
- Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer
- (2020) Eric C. Cheung et al. CANCER CELL
- Doxorubicin Inhibits Phosphatidylserine Decarboxylase and Modifies Mitochondrial Membrane Composition in HeLa Cells
- (2020) Nadège Bellance et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells
- (2020) Jingqiu Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exposure to Chemotherapy During Childhood or Adulthood and Consequences on Spermatogenesis and Male Fertility
- (2020) Marion Delessard et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells
- (2020) Francesca Rolle et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
- (2020) Xiaojing Cheng et al. Cell Death & Disease
- The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway
- (2020) Zhaolin Chen et al. Molecular Therapy-Nucleic Acids
- LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22
- (2020) Kewei Zhu et al. Aging-US
- Canagliflozin inhibits p-gp function and early autophagy and improves the sensitivity to the antitumor effect of doxorubicin
- (2020) Jin Zhong et al. BIOCHEMICAL PHARMACOLOGY
- Antitumour Anthracyclines: Progress and Perspectives
- (2020) Maristela B. Martins‐Teixeira et al. ChemMedChem
- Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment
- (2020) Emilia Licarete et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway
- (2020) Shanshan Lei et al. Experimental and Therapeutic Medicine
- ABCG2 transports anticancer drugs via a closed-to-open switch
- (2020) Benjamin J. Orlando et al. Nature Communications
- Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target
- (2020) Theo Battista et al. Cancers
- miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells
- (2020) Xiaoxin Shi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- miR-199a-5p is involved in doxorubicin resistance of non-small cell lung cancer (NSCLC) cells
- (2020) Yonglong Jin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A novel miR-200c/c-myc negative regulatory feedback loop is essential to the EMT process, CSC biology and drug sensitivity in nasopharyngeal cancer
- (2020) Jing Yang et al. EXPERIMENTAL CELL RESEARCH
- Uncoupling DNA damage from chromatin damage to detoxify doxorubicin
- (2020) Xiaohang Qiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural definition of polyspecific compensatory ligand recognition by P-glycoprotein
- (2020) Christina A. Le et al. IUCrJ
- Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
- (2020) Elizabeth Varghese et al. Cancers
- New insights into the activities and toxicities of the old anticancer drug doxorubicin
- (2020) Sabina Y. van der Zanden et al. FEBS Journal
- Taking advantage of cellular uptake of ferritin nanocages for targeted drug delivery
- (2020) Barbora Tesarova et al. JOURNAL OF CONTROLLED RELEASE
- Curcumin induces chemosensitization to doxorubicin in Duke’s type B coloadenocarcinoma cell line
- (2020) Jeyan Jayarajan et al. MOLECULAR BIOLOGY REPORTS
- Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1α and MDR1
- (2020) Sarah Hassan et al. PLoS One
- Aberrant DNA Methylation of ABC Transporters in Cancer
- (2020) Katja Zappe et al. Cells
- Studying Antitumor Effects of Sirna Gene Silencing of some Metabolic Genes in Pancreatic Ductal Adenocarcinoma
- (2020) Ahmad Sada Al hanjori et al. Current Molecular Pharmacology
- Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
- (2020) Yihan Yao et al. Frontiers in Molecular Biosciences
- Formaldehyde-doxorubicin dual polymeric drug delivery system for higher efficacy and limited cardiotoxicity of anthracyclines
- (2020) Estela Ordonez et al. EUROPEAN POLYMER JOURNAL
- Formononetin exhibits anticancer activity in gastric carcinoma cell and regulating miR ‐542‐5p
- (2020) Wei‐Song Wang et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis
- (2020) Ievgenia Pastushenko et al. NATURE
- A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo
- (2020) Rui-Ming Liu et al. PHYTOMEDICINE
- Suppression of poised oncogenes by ZMYND8 promotes chemo-sensitization
- (2020) Shravanti Mukherjee et al. Cell Death & Disease
- Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization
- (2020) Gennaro Sanità et al. Frontiers in Molecular Biosciences
- miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer
- (2020) Hui Zhang et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
- (2019) Lanlan Gao et al. EBioMedicine
- Early Cardiac Mitochondrial Molecular and Functional Responses to Acute Anthracycline Treatment in Wistar Rats
- (2019) Gonçalo C Pereira et al. TOXICOLOGICAL SCIENCES
- Structural insight into substrate and inhibitor discrimination by human P-glycoprotein
- (2019) Amer Alam et al. SCIENCE
- Ferroptosis as a target for protection against cardiomyopathy
- (2019) Xuexian Fang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- microRNA‐431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma
- (2019) Grace T.Y. Kwok et al. ONCOLOGIST
- The Combined Use of Phenothiazines and Statins Strongly Affects Doxorubicin-Resistance, Apoptosis, and Cox-2 Activity in Colon Cancer Cells
- (2019) Kamila Środa-Pomianek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines
- (2019) Li Chen et al. AAPS PHARMSCITECH
- Dual-Ligand Modification of PEGylated Liposomes Used for Targeted Doxorubicin Delivery to Enhance Anticancer Efficacy
- (2019) Cong Li et al. AAPS PHARMSCITECH
- Integrated high-throughput analysis identifies super enhancers associated with chemoresistance in SCLC
- (2019) Jiarong Bao et al. BMC Medical Genomics
- Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia
- (2019) Salih Demir et al. HAEMATOLOGICA
- Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy
- (2019) Qiang Cai et al. Molecular Cancer
- Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancer
- (2019) Kun Li et al. PHYTOTHERAPY RESEARCH
- Costunolide enhances sensitivity of K562/ADR chronic myeloid leukemia cells to doxorubicin through PI3K/Akt pathway
- (2019) Hong Cai et al. PHYTOTHERAPY RESEARCH
- Metformin prevention of doxorubicin resistance in MCF-7 and MDA-MB-231 involves oxidative stress generation and modulation of cell adaptation genes
- (2019) Poliana Camila Marinello et al. Scientific Reports
- MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer
- (2019) Jinzhi Lai et al. BMC CANCER
- Chemotherapy-induced distal enhancers drive transcriptional program to maintain the chemoresistant state in ovarian cancer.
- (2019) Stephen Shang et al. CANCER RESEARCH
- MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways
- (2019) Cong Liu et al. CELL CYCLE
- Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of Melatonin
- (2019) Javier Menéndez-Menéndez et al. Cancers
- Impaired NF-κB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy
- (2019) Rimpy Dhingra et al. CARDIOVASCULAR RESEARCH
- Doxorubicin and Lovastatin co-delivery liposomes for synergistic therapy of liver cancer
- (2019) Tianying Wang et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
- (2019) Shu Lin et al. Cell Death & Disease
- Downregulation of LncRNA GAS5 promotes liver cancer proliferation and drug resistance by decreasing PTEN expression
- (2019) Congren Wang et al. MOLECULAR GENETICS AND GENOMICS
- Cancer Cell Membrane Decorated Silica Nanoparticle Loaded with miR495 and Doxorubicin to Overcome Drug Resistance for Effective Lung Cancer Therapy
- (2019) Jinyuan He et al. Nanoscale Research Letters
- pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer
- (2019) Sipei Zhang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Targeting CDK12-mediated transcription regulation in anaplastic thyroid carcinoma
- (2019) Meijuan Geng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-149 inhibits cell proliferation and enhances chemosensitivity by targeting CDC42 and BCL2 in neuroblastoma
- (2019) Fengxia Mao et al. Cancer Cell International
- Doxorubicin‐induces NFAT/Fas/FasL cardiac apoptosis in rats through activation of calcineurin and P38 MAPK and inhibition of mTOR signalling pathways
- (2019) Ali A. Shati CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Towards the overcoming of anticancer drug resistance mediated by p53 mutations
- (2019) Xin Cao et al. DRUG RESISTANCE UPDATES
- Mechanisms of Anthracycline-Enhanced Reactive Oxygen Metabolism in Tumor Cells
- (2019) James H. Doroshow Oxidative Medicine and Cellular Longevity
- miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4
- (2019) Feiya Du et al. Cell Death & Disease
- APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells
- (2019) Casey D. Stefanski et al. NEOPLASIA
- Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma
- (2018) Kelong Fan et al. ACS Nano
- Autophagy and doxorubicin resistance in cancer
- (2018) Chao Chen et al. ANTI-CANCER DRUGS
- Extracellular vesicles and anti-Cancer drug resistance
- (2018) Niamh Mc Namee et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer
- (2018) Manxin Xie et al. BIOMEDICINE & PHARMACOTHERAPY
- LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway
- (2018) Xiao-ming Wang et al. CANCER BIOLOGY & THERAPY
- miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1
- (2018) Dawei Wu et al. CANCER GENE THERAPY
- Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs
- (2018) Elimelech Nesher et al. CANCER RESEARCH
- MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer
- (2018) Jin-Won Lee et al. CANCER SCIENCE
- Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer
- (2018) Liang Chang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Self-resistance mechanisms to DNA-damaging antitumor antibiotics in actinobacteria
- (2018) Elodie Tenconi et al. CURRENT OPINION IN MICROBIOLOGY
- Reversal of epigenetic aberrations associated with the acquisition of doxorubicin resistance restores drug sensitivity in breast cancer cells
- (2018) Logeswari Ponnusamy et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling
- (2018) Peter Reichardt et al. Future Oncology
- Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin
- (2018) Ako Azimi et al. GENE
- Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)
- (2018) Johannes M. Waldschmidt et al. HAEMATOLOGICA
- Complete genome sequence of Streptomyces peucetius ATCC 27952, the producer of anticancer anthracyclines and diverse secondary metabolites
- (2018) Dipesh Dhakal et al. JOURNAL OF BIOTECHNOLOGY
- The presence of glutamate residues on the PAS sequence of the stimuli-sensitive nano-ferritin improves in vivo biodistribution and mitoxantrone encapsulation homogeneity
- (2018) Elisabetta Falvo et al. JOURNAL OF CONTROLLED RELEASE
- Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery
- (2018) Iwao Ojima et al. JOURNAL OF NATURAL PRODUCTS
- Chemotherapy medication errors
- (2018) Saul N Weingart et al. LANCET ONCOLOGY
- Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer
- (2018) Mithil Soni et al. MOLECULAR CANCER RESEARCH
- Regulation of antibiotic production in Actinobacteria: new perspectives from the post-genomic era
- (2018) Helga U. van der Heul et al. NATURAL PRODUCT REPORTS
- Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63
- (2018) Marcel Tuppi et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin
- (2018) Souleymane Abdoul-Azize et al. ONCOGENE
- Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1
- (2018) Amer Alam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomas
- (2018) Natalia Saenz-Ponce et al. Science Translational Medicine
- Heterogeneity in tumor chromatin-doxorubicin binding revealed by in vivo fluorescence lifetime imaging confocal endomicroscopy
- (2018) Hugh Sparks et al. Nature Communications
- Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63
- (2018) Marcel Tuppi et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)
- (2018) Johannes M. Waldschmidt et al. HAEMATOLOGICA
- LGR5 promotes epithelial ovarian cancer proliferation, metastasis, and epithelial-mesenchymal transition through the Notch1 signaling pathway
- (2018) Wenxue Liu et al. Cancer Medicine
- pH- and GSH-Sensitive Hyaluronic Acid-MP Conjugate Micelles for Intracellular Delivery of Doxorubicin to Colon Cancer Cells and Cancer Stem Cells
- (2018) Tilahun Ayane Debele et al. BIOMACROMOLECULES
- Pien Tze Huang (片仔癀) Overcomes Doxorubicin Resistance and Inhibits Epithelial-Mesenchymal Transition in MCF-7/ADR Cells
- (2018) Xi Chen et al. Chinese Journal of Integrative Medicine
- A degradable triple temperature-, pH-, and redox-responsive drug system for cancer chemotherapy
- (2018) Bing Yu et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma
- (2018) Xin Xiao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mechanism of drug extrusion by brain endothelial cells via lysosomal drug trapping and disposal by neutrophils
- (2018) Andreas Noack et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthesis and characterization of a photoresponsive doxorubicin/combretastatin A4 hybrid prodrug
- (2018) Wei Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Oleuropein inhibits migration ability through suppression of epithelial-mesenchymal transition and synergistically enhances doxorubicin-mediated apoptosis in MCF-7 cells
- (2018) Jalal Choupani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Enhancing chemosensitivity of breast cancer stem cells by down regulating SOX2 and ABCG2 using Wedelolactone-encapsulated nanoparticles
- (2018) Sreemanti Das et al. MOLECULAR CANCER THERAPEUTICS
- A chemical defence against phage infection
- (2018) Sarah Kronheim et al. NATURE
- Anticancer activity of 2′-hydroxyflavanone towards lung cancer
- (2018) Sanjay Awasthi et al. Oncotarget
- Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment
- (2018) Alina Sesarman et al. Drug Delivery and Translational Research
- The epigallocatechin gallate derivative Y6 reverses drug resistance mediated by the ABCB1 transporter both in vitro and in vivo
- (2018) Yan Wen et al. Acta Pharmaceutica Sinica B
- Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent
- (2018) Jieru Liu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Treatment schedule and estrogen receptor-status influence acquisition of doxorubicin resistance in breast cancer cells
- (2017) Logeswari Ponnusamy et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway
- (2017) Hongyu Shen et al. GENE
- Polymeric nanoparticles: Promising platform for drug delivery
- (2017) Khalid M. El-Say et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer
- (2017) András Füredi et al. JOURNAL OF CONTROLLED RELEASE
- Multifunctional micelle delivery system for overcoming multidrug resistance of doxorubicin
- (2017) Li Qin et al. JOURNAL OF DRUG TARGETING
- Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
- (2017) Jiahui Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo
- (2017) Céline Bouvy et al. LEUKEMIA RESEARCH
- Structural modifications in the sugar moiety as a key to improving the anticancer effectiveness of doxorubicin
- (2017) Marta Denel-Bobrowska et al. LIFE SCIENCES
- Adipocytes Sequester and Metabolize the Chemotherapeutic Daunorubicin
- (2017) Xia Sheng et al. MOLECULAR CANCER RESEARCH
- MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma
- (2017) Ren Chen et al. Molecular Medicine Reports
- Energy transduction and alternating access of the mammalian ABC transporter P-glycoprotein
- (2017) Brandy Verhalen et al. NATURE
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer
- (2017) Shihua Chu et al. ONCOLOGY REPORTS
- Assessment of acute and chronic toxicity of doxorubicin in human induced pluripotent stem cell-derived cardiomyocytes
- (2017) Jochem Louisse et al. TOXICOLOGY IN VITRO
- Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation
- (2017) Zong-Lin Zhang et al. Breast Cancer
- Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells
- (2017) Ilaria Genovese et al. Cell Death & Disease
- MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy
- (2017) Fangfang Jin et al. Cell Death & Disease
- Notch signaling is important for epithelial-mesenchymal transition induced by low concentrations of doxorubicin in osteosarcoma cell lines
- (2017) Jian Yang et al. Oncology Letters
- siRNA-mediated knockdown of ID1 disrupts Nanog- and Oct-4-mediated cancer stem cell-likeness and resistance to chemotherapy in gastric cancer cells
- (2017) Linlin Li et al. Oncology Letters
- MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS
- (2017) Yi Xiao et al. Oncology Letters
- MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway
- (2017) Yan Shu et al. Oncotarget
- Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines
- (2017) Radosław Januchowski et al. Oncotarget
- Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy
- (2017) Zhengguang Wang et al. Oncotarget
- LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1
- (2017) Zhu Kun-Peng et al. Oncotarget
- Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
- (2017) Dongxi Xiang et al. Theranostics
- Transformation of the Anticancer Drug Doxorubicin in the Human Gut Microbiome
- (2017) Austin Yan et al. ACS Infectious Diseases
- Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress
- (2017) Amara Maryam et al. Scientific Reports
- The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes
- (2017) Stefano Palazzolo et al. CURRENT MEDICINAL CHEMISTRY
- Doxorubicin-induced epithelial–mesenchymal transition through SEMA 4A in hepatocellular carcinoma
- (2016) Jie-Xue Pan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy
- (2016) J. J. Bartlett et al. BIOCHEMICAL JOURNAL
- New signal transduction paradigms in anthracycline-induced cardiotoxicity
- (2016) Alessandra Ghigo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Combined cancer therapy with hyaluronan-decorated fullerene-silica multifunctional nanoparticles to target cancer stem-like cells
- (2016) Hai Wang et al. BIOMATERIALS
- Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia
- (2016) S. Piya et al. BLOOD
- Erratum to: APC selectively mediates response to chemotherapeutic agents in breast cancer
- (2016) Monica K. VanKlompenberg et al. BMC CANCER
- Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells
- (2016) Baoqing Guo et al. BMC CANCER
- Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome AcidificationCLINICAL PERSPECTIVE
- (2016) Dan L. Li et al. CIRCULATION
- Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles
- (2016) Yang Wu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- ABC transporters as mediators of drug resistance and contributors to cancer cell biology
- (2016) Jamie I. Fletcher et al. DRUG RESISTANCE UPDATES
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Molecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid Leukemia
- (2016) Gene C. Jamieson et al. DRUGS
- MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway
- (2016) Hongyu Shen et al. GENE
- A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses
- (2016) Eric H. Bent et al. GENES & DEVELOPMENT
- ESHRE Guideline: management of women with premature ovarian insufficiency
- (2016) HUMAN REPRODUCTION
- A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma
- (2016) MASAFUMI YAMASHITA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Multimodal transfer of MDR by exosomes in human osteosarcoma
- (2016) ELENA TORREGGIANI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors
- (2016) Golam Kibria et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity
- (2016) Lothar Esser et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness
- (2016) Giulio Fracasso et al. JOURNAL OF CONTROLLED RELEASE
- MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
- (2016) Lin Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Correlation of in Situ Oxazolidine Formation with Highly Synergistic Cytotoxicity and DNA Cross-Linking in Cancer Cells from Combinations of Doxorubicin and Formaldehyde
- (2016) Benjamin L. Barthel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism
- (2016) Ann-Marie Meredith et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models
- (2016) Mohamad Hadla et al. Nanomedicine
- Decursin inAngelica gigasNakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADR-RES Ovarian Cancer Cells via Inhibition of P-glycoprotein Expression
- (2016) Hyeong Sim Choi et al. PHYTOTHERAPY RESEARCH
- Inhibition of human anthracycline reductases by emodin — A possible remedy for anthracycline resistance
- (2016) Jan Hintzpeter et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway
- (2016) Dan-dan Wang et al. TUMOR BIOLOGY
- The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration
- (2016) A E Hall et al. Cell Death & Disease
- miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
- (2016) Y Hu et al. Cell Death & Disease
- miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1
- (2016) Man Gao et al. Oncotarget
- Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia
- (2016) Lifen Zhao et al. Oncotarget
- MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway
- (2016) Zhiyun Zheng et al. Oncotarget
- Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3
- (2016) Bing Tu et al. Oncotarget
- A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer
- (2016) Do Yeon Kim et al. Oncotarget
- Amrubicin for relapsed small-cell lung cancer: a systematic review and meta-analysis of 803 patients
- (2016) Nobuyuki Horita et al. Scientific Reports
- Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE2
- (2016) Yuan Rong et al. Scientific Reports
- MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program
- (2016) Jing Xu et al. Cell Discovery
- Multidrug Resistance Proteins (MRPs) and Cancer Therapy
- (2015) Yun-Kai Zhang et al. AAPS Journal
- Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts
- (2015) Tae Hyung Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- MAPK/JNK signaling: A potential autophagy regulation pathway
- (2015) Yuan-Yuan Zhou et al. BIOSCIENCE REPORTS
- MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1
- (2015) Lin Lu et al. BIOTECHNOLOGY LETTERS
- Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors
- (2015) Man Yu et al. CANCER SCIENCE
- Serine 574 phosphorylation alters transcriptional programming of FOXO3 by selectively enhancing apoptotic gene expression
- (2015) Z Li et al. CELL DEATH AND DIFFERENTIATION
- Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo–keto reductase 1B10
- (2015) Yoshifumi Morikawa et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone
- (2015) R. Koch et al. CLINICAL CANCER RESEARCH
- Targeting Microparticle Biogenesis: A Novel Approach to the Circumvention of Cancer Multidrug Resistance
- (2015) Ariane Roseblade et al. CURRENT CANCER DRUG TARGETS
- Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines
- (2015) Derek Edwardson et al. CURRENT DRUG METABOLISM
- Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach
- (2015) Sophie Taylor et al. DRUG RESISTANCE UPDATES
- Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery
- (2015) Huan Xu et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells
- (2015) Ji Na Kong et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin
- (2015) Leila Arabi et al. JOURNAL OF CONTROLLED RELEASE
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia
- (2015) Limin Liu et al. LEUKEMIA RESEARCH
- RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma
- (2015) M. Hazar-Rethinam et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-215 is upregulated by treatment with Adriamycin and leads to the chemoresistance of hepatocellular carcinoma cells and tissues
- (2015) LI WANG et al. Molecular Medicine Reports
- Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin
- (2015) Giuseppe Toffoli et al. Nanomedicine
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Chemical profiling of the genome with anti-cancer drugs defines target specificities
- (2015) Baoxu Pang et al. Nature Chemical Biology
- MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy
- (2015) RUIDA XU et al. ONCOLOGY REPORTS
- Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
- (2015) Renata Silva et al. PHARMACOLOGY & THERAPEUTICS
- The Mitochondrial Permeability Transition Pore: Channel Formation by F-ATP Synthase, Integration in Signal Transduction, and Role in Pathophysiology
- (2015) Paolo Bernardi et al. PHYSIOLOGICAL REVIEWS
- Comparative proteomics analysis of differential proteins in respond to doxorubicin resistance in myelogenous leukemia cell lines
- (2015) Shi Qinghong et al. Proteome Science
- pH Gradient Reversal: An Emerging Hallmark of Cancers
- (2015) Mohit Sharma et al. Recent Patents on Anti-Cancer Drug Discovery
- APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
- (2015) N Mohell et al. Cell Death & Disease
- Whole-exome analysis reveals novel somatic genomic alterations associated with outcome in immunochemotherapy-treated diffuse large B-cell lymphoma
- (2015) A J Novak et al. Blood Cancer Journal
- Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation
- (2015) Yue Zhou et al. Oncotarget
- Structural basis of Sorcin-mediated calcium-dependent signal transduction
- (2015) Andrea Ilari et al. Scientific Reports
- Doxorubicin-induced necrosis is mediated by poly-(ADP-ribose) polymerase 1 (PARP1) but is independent of p53
- (2015) Hyeon-Jun Shin et al. Scientific Reports
- Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs
- (2015) Caecilia HC Sukowati et al. Expert Review of Gastroenterology & Hepatology
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- Snapshots of ligand entry, malleable binding and induced helical movement in P-glycoprotein
- (2015) Paul Szewczyk et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults
- (2015) Richard A Anderson et al. Lancet Diabetes & Endocrinology
- Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models
- (2015) Jonathan Rios-Doria et al. NEOPLASIA
- Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice
- (2015) Jenna Kropp et al. PLoS One
- miR-17/20 sensitization of breast cancer cells to chemotherapy-induced apoptosis requires Akt1
- (2015) Zuoren Yu et al. Oncotarget
- 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin
- (2015) Dong-Gun Kim et al. Oncotarget
- Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance
- (2015) Eran E. Bram et al. NEOPLASIA
- Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
- (2014) Qingcheng Mao et al. AAPS Journal
- Reversing Effect of Sorcin in the Drug Resistance of Human Nasopharyngeal Carcinoma
- (2014) Xuebing Liu et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- An Epigenetic Mechanism Underlying Doxorubicin Induced EMT in the Human BGC-823 Gastric Cancer Cell
- (2014) Rong-Fei Han et al. Asian Pacific Journal of Cancer Prevention
- Triggered Release of Doxorubicin from Temperature-Sensitive Poly(N-(2-hydroxypropyl)-methacrylamide mono/dilactate) Grafted Liposomes
- (2014) Merel van Elk et al. BIOMACROMOLECULES
- Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line
- (2014) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Novel Suppressive Effects of Ketotifen on Migration and Invasion of MDA-MB-231 and HT-1080 Cancer Cells
- (2014) Hyun Ji Kim et al. Biomolecules & Therapeutics
- A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer
- (2014) Yifan Tu et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation
- (2014) Zhen Zhao et al. CANCER BIOLOGY & THERAPY
- Angiocrine Factors Deployed by Tumor Vascular Niche Induce B Cell Lymphoma Invasiveness and Chemoresistance
- (2014) Zhongwei Cao et al. CANCER CELL
- Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance
- (2014) E. Y. Park et al. CANCER RESEARCH
- A Novel E2F/Sphingosine Kinase 1 Axis Regulates Anthracycline Response in Squamous Cell Carcinoma
- (2014) M. Hazar-Rethinam et al. CLINICAL CANCER RESEARCH
- Microvesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistance
- (2014) Fang-fang Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Doxorubicin alters the mitochondrial dynamics machinery and mitophagy in the liver of treated animals
- (2014) Amie J. Dirks-Naylor et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Gene expression alterations in chronic hypoxic MCF7 breast cancer cell line
- (2014) Feda' H. Hamdan et al. GENOMICS
- In vivodisposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters
- (2014) Selvi Durmus et al. INTERNATIONAL JOURNAL OF CANCER
- The pterocarpanquinone LQB-118 induces apoptosis in acute myeloid leukemia cells of distinct molecular subtypes and targets FoxO3a and FoxM1 transcription factors
- (2014) GABRIELA NESTAL DE MORAES et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Localized delivery of doxorubicin in vivo from polymer-modified thermosensitive liposomes with MR-guided focused ultrasound-mediated heating
- (2014) Terence Ta et al. JOURNAL OF CONTROLLED RELEASE
- Targeted and heat-triggered doxorubicin delivery to tumors by dual targeted cationic thermosensitive liposomes
- (2014) Bilyana M. Dicheva et al. JOURNAL OF CONTROLLED RELEASE
- Lipopolysaccharide-Induced Expression of NAD(P)H:Quinone Oxidoreductase 1 and Heme Oxygenase-1 Protects against Excessive Inflammatory Responses in Human Monocytes
- (2014) S. A. Rushworth et al. JOURNAL OF IMMUNOLOGY
- MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3
- (2014) Na Zhao et al. Molecular Cancer
- Targeted polytherapy in small cell sarcoma and its association with doxorubicin
- (2014) S.N. Dumont et al. Molecular Oncology
- Codelivery of Doxorubicin and Paclitaxel by Cross-Linked Multilamellar Liposome Enables Synergistic Antitumor Activity
- (2014) Yarong Liu et al. MOLECULAR PHARMACEUTICS
- Synergistic Dual-Ligand Doxorubicin Liposomes Improve Targeting and Therapeutic Efficacy of Brain Glioma in Animals
- (2014) Taili Zong et al. MOLECULAR PHARMACEUTICS
- Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
- (2014) Bernardo Tavora et al. NATURE
- Bacterial solutions to multicellularity: a tale of biofilms, filaments and fruiting bodies
- (2014) Dennis Claessen et al. NATURE REVIEWS MICROBIOLOGY
- Regulation of BGC-823 cell sensitivity to adriamycin via miRNA-135a-5p
- (2014) YANMING PAN et al. ONCOLOGY REPORTS
- Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma
- (2014) Mike-Andrew Westhoff et al. PLoS One
- Sorcin Links Calcium Signaling to Vesicle Trafficking, Regulates Polo-Like Kinase 1 and Is Necessary for Mitosis
- (2014) Vasiliki S. Lalioti et al. PLoS One
- Exosomes from Drug-Resistant Breast Cancer Cells Transmit Chemoresistance by a Horizontal Transfer of MicroRNAs
- (2014) Wei-xian Chen et al. PLoS One
- Bortezomib Prevents Acute Doxorubicin Ovarian Insult and Follicle Demise, Improving the Fertility Window and Pup Birth Weight in Mice
- (2014) Elon C. Roti Roti et al. PLoS One
- Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance
- (2014) X. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection
- (2014) M. Liang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment
- (2014) D Ciavardelli et al. Cell Death & Disease
- Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer
- (2014) Kenji Takahashi et al. FEBS Open Bio
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant Tumors
- (2013) Su Chul Jang et al. ACS Nano
- Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity
- (2013) Marzia Lotrionte et al. AMERICAN JOURNAL OF CARDIOLOGY
- Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Doxorubicin-antioxidant co-drugs
- (2013) Konstantin Chegaev et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues
- (2013) Krupa J. Patel et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Octa-arginine-modified pegylated liposomal doxorubicin: An effective treatment strategy for non-small cell lung cancer
- (2013) Swati Biswas et al. CANCER LETTERS
- CDK4 inhibition restores G₁-S arrest inMYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage
- (2013) Sina Gogolin et al. CELL CYCLE
- An Engineered Bivalent Neuregulin Protects Against Doxorubicin-Induced Cardiotoxicity With Reduced Proneoplastic Potential
- (2013) Steven M. Jay et al. CIRCULATION
- Doxorubicin Enhances Nucleosome Turnover around Promoters
- (2013) Fan Yang et al. CURRENT BIOLOGY
- MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells
- (2013) Tao Yang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Downregulation of histone deacetylase 1 by microRNA-520h contributes to the chemotherapeutic effect of doxorubicin
- (2013) Qi Shen et al. FEBS LETTERS
- Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
- (2013) Yuting Ma et al. IMMUNITY
- Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling
- (2013) Erik Wennerberg et al. INTERNATIONAL JOURNAL OF CANCER
- Maspin influences response to doxorubicin by changing the tumor microenvironment organization
- (2013) Tiziana Triulzi et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer
- (2013) BERLINDA VERDOODT et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Magnetic Resonance Guided High-Intensity Focused Ultrasound Mediated Hyperthermia Improves the Intratumoral Distribution of Temperature-Sensitive Liposomal Doxorubicin
- (2013) Mariska de Smet et al. INVESTIGATIVE RADIOLOGY
- Overexpressed nuclear BAG-1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin
- (2013) Wenkai Ni et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy
- (2013) Hamidreza Montazeri Aliabadi et al. JOURNAL OF CONTROLLED RELEASE
- Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy
- (2013) Li Li et al. JOURNAL OF CONTROLLED RELEASE
- MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity
- (2013) Leibo Xu et al. JOURNAL OF HEPATOLOGY
- F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity
- (2013) A Kruczynski et al. LEUKEMIA
- miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling
- (2013) YONG CHEN et al. Molecular Medicine Reports
- Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells
- (2013) Martin Werner et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells
- (2013) A A Takwi et al. ONCOGENE
- Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells
- (2013) Anna Vavrova et al. PLoS One
- Peptide-Mediated Liposomal Doxorubicin Enhances Drug Delivery Efficiency and Therapeutic Efficacy in Animal Models
- (2013) De-Kuan Chang et al. PLoS One
- Changes in the Expression of miR-381 and miR-495 Are Inversely Associated with the Expression of the MDR1 Gene and Development of Multi-Drug Resistance
- (2013) Yan Xu et al. PLoS One
- Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain
- (2013) A. B. Ward et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human ferritin for tumor detection and therapy
- (2013) Kelong Fan et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
- (2013) Baoxu Pang et al. Nature Communications
- MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
- (2013) Jessica Bockhorn et al. Nature Communications
- Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298
- (2012) Lili Bao et al. AMERICAN JOURNAL OF PATHOLOGY
- IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling
- (2012) Sonja M. Kessler et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1
- (2012) Xiu-juan Li et al. ARCHIVES OF MEDICAL RESEARCH
- Processing of anthracycline-DNA adducts via DNA replication and interstrand crosslink repair pathways
- (2012) R.A. Bilardi et al. BIOCHEMICAL PHARMACOLOGY
- Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation
- (2012) Robert A. Forrest et al. BIOCHEMICAL PHARMACOLOGY
- Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity
- (2012) Balindiwe J.N. Sishi et al. BIOCHEMICAL PHARMACOLOGY
- Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia
- (2012) Wafa' T. Al-Jamal et al. BIOMATERIALS
- The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer
- (2012) Zhaohui Wang et al. BIOMATERIALS
- Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation
- (2012) Zhen Zeng et al. BMC CANCER
- Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization
- (2012) Allan D Heibein et al. BMC CANCER
- Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma
- (2012) Youhei Tanaka et al. CANCER
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
- (2012) Jueng Soo You et al. CANCER CELL
- p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
- (2012) James G. Jackson et al. CANCER CELL
- Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin
- (2012) Mostafa Shahin et al. CANCER LETTERS
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- Bacterial Inactivation of the Anticancer Drug Doxorubicin
- (2012) Erin L. Westman et al. CHEMISTRY & BIOLOGY
- The UCSF-FDA TransPortal: A Public Drug Transporter Database
- (2012) K M Morrissey et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Structural and Functional Properties of Human Multidrug Resistance Protein 1 (MRP1/ABCC1)
- (2012) S.-M. He et al. CURRENT MEDICINAL CHEMISTRY
- Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
- (2012) A. Palmeira et al. CURRENT MEDICINAL CHEMISTRY
- Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties
- (2012) Ngoc Bich Vu et al. CYTOTECHNOLOGY
- Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats
- (2012) Zhongya Chen et al. International Journal of Nanomedicine
- Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice
- (2012) François-Xavier Dieudonné et al. JOURNAL OF BONE AND MINERAL RESEARCH
- FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3
- (2012) J. Hagenbuchner et al. JOURNAL OF CELL SCIENCE
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
- (2012) Yanti Octavia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2
- (2012) Francesca Fornari et al. JOURNAL OF PATHOLOGY
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
- (2012) Christoph Mamot et al. LANCET ONCOLOGY
- PEGylated Liposomal Doxorubicin Targeted to α5β1-Expressing MDA-MB-231 Breast Cancer Cells
- (2012) Kamlesh Shroff et al. LANGMUIR
- Topological domains in mammalian genomes identified by analysis of chromatin interactions
- (2012) Jesse R. Dixon et al. NATURE
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Berberine Inhibits Doxorubicin-Triggered Cardiomyocyte Apoptosis via Attenuating Mitochondrial Dysfunction and Increasing Bcl-2 Expression
- (2012) Xiuxiu Lv et al. PLoS One
- Heat shock factor-1 knockout induces multidrug resistance gene, MDR1b, and enhances P-glycoprotein (ABCB1)-based drug extrusion in the heart
- (2012) K. Krishnamurthy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity
- (2012) Joseph G. Reynolds et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma
- (2012) Cheng-lin Yang et al. TUMOR BIOLOGY
- Activation of β-catenin signaling is critical for doxorubicin-induced epithelial–mesenchymal transition in BGC-823 gastric cancer cell line
- (2012) Rongfei Han et al. TUMOR BIOLOGY
- Mechanism of Generation of Therapy Related Leukemia in Response to Anti-Topoisomerase II Agents
- (2012) Ian G. Cowell et al. International Journal of Environmental Research and Public Health
- Remote Triggered Release of Doxorubicin in Tumors by Synergistic Application of Thermosensitive Liposomes and Gold Nanorods
- (2011) Abhiruchi Agarwal et al. ACS Nano
- SIRT1 Promotes Tumorigenesis and Resistance to Chemotherapy in Hepatocellular Carcinoma and its Expression Predicts Poor Prognosis
- (2011) Hsieh-Cheng Chen et al. ANNALS OF SURGICAL ONCOLOGY
- MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN
- (2011) Zhao-Xia Wang et al. ARCHIVES OF MEDICAL RESEARCH
- MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines
- (2011) Hege O Ohnstad et al. BMC CANCER
- The semisynthetic flavonoid monoHER sensitises human soft tissue sarcoma cells to doxorubicin-induced apoptosis via inhibition of nuclear factor-κB
- (2011) H Jacobs et al. BRITISH JOURNAL OF CANCER
- Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
- (2011) S. R. Mattarollo et al. CANCER RESEARCH
- Tumor Suppressor miR-22 Determines p53-Dependent Cellular Fate through Post-transcriptional Regulation of p21
- (2011) N. Tsuchiya et al. CANCER RESEARCH
- Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth
- (2011) J. Chen et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- PIK3CA mutations in human solid tumors: Role in sensitivity to various therapeutic approaches
- (2011) Giovanni Ligresti et al. CELL CYCLE
- Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs
- (2011) Rosa Puca et al. CELL CYCLE
- Substrate and product specificities of SET domain methyltransferases
- (2011) Paul A. Del Rizzo et al. Epigenetics
- Cardioprotective effect of ascorbic acid on doxorubicin-induced myocardial toxicity in rats
- (2011) A.H.M Viswanatha Swamy et al. INDIAN JOURNAL OF PHARMACOLOGY
- RNA Interference Targeting Slug Increases Cholangiocarcinoma Cell Sensitivity to Cisplatin via Upregulating PUMA
- (2011) Kejun Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin
- (2011) Ka-Kei Ho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin
- (2011) Tatsuaki Tagami et al. JOURNAL OF CONTROLLED RELEASE
- Involvement of the NF-κB pathway in multidrug resistance induced by HBx in a hepatoma cell line
- (2011) Y. Liu et al. JOURNAL OF VIRAL HEPATITIS
- Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer
- (2011) Junqing Chen et al. MEDICAL ONCOLOGY
- Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin
- (2011) Wei Wei et al. Molecular Cancer
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
- (2011) B. Diop-Frimpong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncogenic Wip1 Phosphatase Is Inhibited by miR-16 in the DNA Damage Signaling Pathway
- (2010) X. Zhang et al. CANCER RESEARCH
- MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
- (2010) Francesca Fornari et al. CANCER RESEARCH
- Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
- (2010) Y. Zhao et al. CANCER RESEARCH
- The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy
- (2010) Stephen L. Abrams et al. CELL CYCLE
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway
- (2010) Xiao Qi Wang et al. HEPATOLOGY
- Foxo3a Regulates Apoptosis by Negatively Targeting miR-21
- (2010) Kun Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways
- (2010) Tongsen Zheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell
- (2010) Min-Bin Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CD13 is a therapeutic target in human liver cancer stem cells
- (2010) Naotsugu Haraguchi et al. JOURNAL OF CLINICAL INVESTIGATION
- Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy
- (2010) Michael F. Press et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors
- (2010) Amanda Lowery et al. JOURNAL OF CONTROLLED RELEASE
- Activation of the cardiac Na+–Ca2+ exchanger by sorcin via the interaction of the respective Ca2+-binding domains
- (2010) Carlotta Zamparelli et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Doxorubicin induces mitochondrial permeability transition and contractile dysfunction in the human myocardium
- (2010) David Montaigne et al. MITOCHONDRION
- Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL
- (2010) Alena Vaculova et al. Molecular Cancer
- Autophagy Induction with RAD001 Enhances Chemosensitivity and Radiosensitivity through Met Inhibition in Papillary Thyroid Cancer
- (2010) C.-I. Lin et al. MOLECULAR CANCER RESEARCH
- Magnetic tweezers measurements of the nanomechanical properties of DNA in the presence of drugs
- (2010) D. Salerno et al. NUCLEIC ACIDS RESEARCH
- Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer
- (2010) Jie Chen et al. PLoS One
- Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer
- (2010) Constanze Zeller et al. Therapeutic Advances in Medical Oncology
- PARP-1 is involved in autophagy induced by DNA damage
- (2009) José Antonio Muñoz-Gámez et al. Autophagy
- NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis
- (2009) Mylène Gilleron et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line
- (2009) Roberto Mazzanti et al. BIOCHEMICAL PHARMACOLOGY
- Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to Adriamycin
- (2009) Xu Di et al. BIOCHEMICAL PHARMACOLOGY
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- Nucleosome Assembly Depends on the Torsion in the DNA Molecule: A Magnetic Tweezers Study
- (2009) Pooja Gupta et al. BIOPHYSICAL JOURNAL
- Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia
- (2009) A. N. Mays et al. BLOOD
- Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)
- (2009) R.C.F. Leonard et al. BREAST
- Moderate Increase in Mdr1a/1b Expression Causes In vivo Resistance to Doxorubicin in a Mouse Model for Hereditary Breast Cancer
- (2009) M. Pajic et al. CANCER RESEARCH
- MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
- (2009) F. Fornari et al. CANCER RESEARCH
- Doxorubicin Cardiomyopathy
- (2009) Kanu Chatterjee et al. CARDIOLOGY
- Targeting the PI3K signaling pathway in cancer
- (2009) Kwok-Kin Wong et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- The combined status of ATM and p53 link tumor development with therapeutic response
- (2009) H. Jiang et al. GENES & DEVELOPMENT
- INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model
- (2009) R. Graeser et al. INVESTIGATIONAL NEW DRUGS
- Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells
- (2009) M Bebawy et al. LEUKEMIA
- Repression of BIRC5/Survivin by FOXO3/FKHRL1 Sensitizes Human Neuroblastoma Cells to DNA Damage-induced Apoptosis
- (2009) Petra Obexer et al. MOLECULAR BIOLOGY OF THE CELL
- iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
- (2009) Sara De Boo et al. Molecular Cancer
- ABCB8 Mediates Doxorubicin Resistance in Melanoma Cells by Protecting the Mitochondrial Genome
- (2009) Aaron M. Elliott et al. MOLECULAR CANCER RESEARCH
- Sensors and regulators of intracellular pH
- (2009) Joseph R. Casey et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance
- (2009) Zachary W. Veitch et al. Pharmacogenetics and Genomics
- Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells
- (2009) K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- When apoptosis meets autophagy: deciding cell fate after trauma and sepsis
- (2009) Ya-Ching Hsieh et al. TRENDS IN MOLECULAR MEDICINE
- Cancer stem cell epigenetics and chemoresistance
- (2009) Francesco Crea et al. Epigenomics
- Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent
- (2008) Abdelhadi Rebbaa et al. ANGIOGENESIS
- Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs
- (2008) Neil Ashley et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
- (2008) Hua Zhu et al. BIOCHEMICAL PHARMACOLOGY
- A role for ceramide in driving cancer cell resistance to doxorubicin
- (2008) Yong-Yu Liu et al. FASEB JOURNAL
- Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer
- (2008) Tatsuhiro Shibata et al. GASTROENTEROLOGY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration
- (2008) B Chapuy et al. LEUKEMIA
- Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance
- (2008) J A McCubrey et al. LEUKEMIA
- The Forkhead Transcription Factor FOXO3a Increases Phosphoinositide-3 Kinase/Akt Activity in Drug-Resistant Leukemic Cells through Induction of PIK3CA Expression
- (2008) R. C.-Y. Hui et al. MOLECULAR AND CELLULAR BIOLOGY
- MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression
- (2008) I. Ivanovska et al. MOLECULAR AND CELLULAR BIOLOGY
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNAs modulate the chemosensitivity of tumor cells
- (2008) P. E. Blower et al. MOLECULAR CANCER THERAPEUTICS
- Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters
- (2008) M. Okabe et al. MOLECULAR CANCER THERAPEUTICS
- Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells
- (2008) R. C-Y. Hui et al. MOLECULAR CANCER THERAPEUTICS
- Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer
- (2008) Maha Saad et al. Nanomedicine
- Principles of bioactive lipid signalling: lessons from sphingolipids
- (2008) Yusuf A. Hannun et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
- (2008) K. E. Coldwell et al. NUCLEIC ACIDS RESEARCH
- Dexrazoxane (TotectTM): FDA Review and Approval for the Treatment of Accidental Extravasation Following Intravenous Anthracycline Chemotherapy
- (2008) R. C. Kane et al. ONCOLOGIST
- Topoisomerase levels determine chemotherapy responsein vitroandin vivo
- (2008) Darren J. Burgess et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- P-glycoprotein: So Many Ways to Turn It On
- (2007) Richard Callaghan et al. JOURNAL OF CLINICAL PHARMACOLOGY
- DNA repair in response to anthracycline–DNA adducts: A role for both homologous recombination and nucleotide excision repair
- (2007) Damian M.S. Spencer et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- ABC multidrug transporters: structure, function and role in chemoresistance
- (2007) Frances J Sharom PHARMACOGENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More